Navigation Links
Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
Date:12/3/2010

er of 2011, that CTI's appeal may not be successful, that the FDA may not approve CTI's SPA, that the EMA may not approve CTI's MAA after review and CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.Media Contact:Dan Eramian T: 206.272.4343C: 206.854.1200E: deramian@ctiseattle.comKristin MacIntoshT: 206.272.4490E: kmacintosh@ctiseattle.comwww.CellTherapeutics.com/press_room Investors Contact:Ed BellT: 206.282.7100Lindsey Jesch LoganT: 206.272.4347F: 206.272.4434E: invest@ctiseattle.com www.CellTherapeutics.com/investorsMedical Information Contact:T: 800.715.0944E: info@askarm.com
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Most osteoporosis patients want a choice ... online survey* sponsored by Mission Pharmacal Company. The survey, ... Foundation online support community, revealed that 74 percent of ... in a form other than a pill or a ...
(Date:1/15/2014)... 2014 As health officials across the Midwest warn against ... in Michigan will offer free diagnostic ... Meijer pharmacists to administer tests and, in some cases, fill ... participating in the study. The Grand ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health care ... new IT value-added reseller (VAR) national contracts that expand ... and services at lower costs. These include manufacturer product ... as initiative assistance and ongoing IT consulting support. ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2
... Jan. 24, 2012 Cardon Healthcare Network today announced ... the two companies. The combined company will be named ... TX. The core business of both ... for the self-pay segment of their patient populations.  Cardon ...
... 2012  Precision Therapeutics, Inc. has recently expanded ... biomarkers to help physicians with their treatment ... cancer care by offering additional molecular markers, ... utilizing BioSpeciFx® results in combination with Precision ...
Cached Medicine Technology:Outreach Services Merger With Cardon Healthcare Creates Largest Provider of Eligibility Services to Hospitals 2Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care 2
(Date:4/23/2014)... The internal surface area of the gastro-intestinal tract has ... square meters. Scientists at the Sahlgrenska Academy have used ... , "Actually, the inner surface of the gastro-intestinal tract ... says scientist Lars Fndriks. , The digestive tract, which ... through the intestines, has a length of about 5 ...
(Date:4/23/2014)... mounts showing the potential health benefits of probiotics, antioxidants ... taking supplements. And the chemical industry is getting in ... effects could deter growth, so the industry is responding ... to the cover story in Chemical & Engineering ... American Chemical Society. , Melody M. Bomgardner, a senior ...
(Date:4/23/2014)... an increase in adolescents, marijuana use following the legalization ... According to a new study at Rhode Island Hospital ... with and without medical marijuana laws, legalizing the drug ... study is published online in advance of print in ... "Any time a state considers legalizing medical marijuana, there ...
(Date:4/23/2014)... Getting to the bottom of Alzheimer,s disease has ... turns and controversies. In the latest crook in ... insight into the interaction between proteins associated with ... journal ACS Chemical Neuroscience , could have ... K. Surewicz, Krzysztof Nieznanski and colleagues explain that ...
(Date:4/22/2014)... for low-income patients may ease the financial burden ... patient health, researchers have concluded. , A study ... avoid costs associated with insurance administration can help ... and emergency room visits, according to Mark Agee, ... The researchers estimated that the major hospital in ...
Breaking Medicine News(10 mins):Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:Clinics not bogged down by red tape can ease health cost burdens 2
... PHILADELPHIA, March 13 Marathon Mark Leventhal, ... Incorporated --, http://www.attorneyweightloss.com -- the first ... for attorneys by an attorney -- is ... the Young Lawyer ("YL") in an article,entitled ...
... can modestly increase the amount of physical activity among ... the Trial of Activity for Adolescent Girls (TAAG), a ... Heart, Lung, and Blood Institute (NHLBI) of the National ... the article, "Promoting Physical Activity in Middle School Girls," ...
... Scientists at the Massachusetts General Hospital (MGH) have ... 1 diabetes. The trial is exploring whether the ... PhD, can be applied in human diabetes. Faustmans previous ... diabetes that closely resembles type 1 diabetes in humans ...
... Calif., March 13 Take Care Health Systems,one ... and a wholly-owned,subsidiary of Walgreens (NYSE, Nasdaq: WAG), ... Partners (BSSP), a full-service marketing,communications firm headquartered in ... record., BSSP is tasked with developing Take ...
... say the next major disease like HIV/AIDS or ... of developing countries concentrated along the equator. ... of a potential outbreak., ,Using global databases and ... diseases, the researchers -- from the Consortium for ...
... troubling link between boom towns and high rates of substance ... and too little to do. But a recent study of ... of healthy social connections and a need to keep up ... researchers, working with the Canadian Forest Service to conduct the ...
Cached Medicine News:Health News:Leventhal Weight Loss Incorporated President Featured on Cover of Young Lawyer 2Health News:After-school programs can increase physical activity of adolescent girls 2Health News:MGH initiates phase I diabetes trial 2Health News:Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record 2Health News:Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record 3Health News:Scientists say tropics are next emerging disease hotspot 2Health News:Scientists say tropics are next emerging disease hotspot 3Health News:Study names 5 factors of social ills in energy, mining and logging communities 2
Malis CMC-III Generator provides both coagulation and cutting outputs....
...
...
...
Medicine Products: